Literature DB >> 20415480

Coordinating radiometals of copper, gallium, indium, yttrium, and zirconium for PET and SPECT imaging of disease.

Thaddeus J Wadas1, Edward H Wong, Gary R Weisman, Carolyn J Anderson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20415480      PMCID: PMC2874951          DOI: 10.1021/cr900325h

Source DB:  PubMed          Journal:  Chem Rev        ISSN: 0009-2665            Impact factor:   60.622


× No keyword cloud information.
  434 in total

1.  A clinical trial of radioimmunotherapy with 67Cu-2IT-BAT-Lym-1 for non-Hodgkin's lymphoma.

Authors:  R T O'Donnell; G L DeNardo; D L Kukis; K R Lamborn; S Shen; A Yuan; D S Goldstein; C E Carr; G R Mirick; S J DeNardo
Journal:  J Nucl Med       Date:  1999-12       Impact factor: 10.057

Review 2.  Radioimmunotherapy: potential as a therapeutic strategy in non-Hodgkin's lymphoma.

Authors:  T Wun; D S Kwon; J M Tuscano
Journal:  BioDrugs       Date:  2001       Impact factor: 5.807

3.  A triglycine linker improves tumor uptake and biodistributions of 67-Cu-labeled anti-neuroblastoma MAb chCE7 F(ab')2 fragments.

Authors:  K Zimmermann; S Gianollini; P A Schubiger; I Novak-Hofer
Journal:  Nucl Med Biol       Date:  1999-11       Impact factor: 2.408

Review 4.  Positron-emitting isotopes produced on biomedical cyclotrons.

Authors:  Paul McQuade; Douglas J Rowland; Jason S Lewis; Michael J Welch
Journal:  Curr Med Chem       Date:  2005       Impact factor: 4.530

5.  Transfer of copper from a chelated 67Cu-antibody conjugate to ceruloplasmin in lymphoma patients.

Authors:  G R Mirick; R T O'Donnell; S J DeNardo; S Shen; C F Meares; G L DeNardo
Journal:  Nucl Med Biol       Date:  1999-10       Impact factor: 2.408

6.  Assessment of Cu-ETS as a PET radiopharmaceutical for evaluation of regional renal perfusion.

Authors:  Mark A Green; Carla J Mathias; Lynn R Willis; Rajash K Handa; Jeffrey L Lacy; Michael A Miller; Gary D Hutchins
Journal:  Nucl Med Biol       Date:  2007-04       Impact factor: 2.408

7.  Ternary complex formation facilitates a redox mechanism for iron release from a siderophore.

Authors:  Kassy A Mies; Joseph I Wirgau; Alvin L Crumbliss
Journal:  Biometals       Date:  2006-04       Impact factor: 2.949

8.  A pilot trial of quantitative Tc-99m HMPAO and Ga-67 citrate lung scans to detect pulmonary vascular endothelial damage and lung inflammation in patients of collagen vascular diseases with active diffuse infiltrative lung disease.

Authors:  L W Hang; W H Hsu; J J P Tsai; Y F Jim; C C Lin; A Kao
Journal:  Rheumatol Int       Date:  2003-06-28       Impact factor: 2.631

9.  Receptor-binding, biodistribution, and metabolism studies of 64Cu-DOTA-cetuximab, a PET-imaging agent for epidermal growth-factor receptor-positive tumors.

Authors:  Wen Ping Li; Laura A Meyer; David A Capretto; Christopher D Sherman; Carolyn J Anderson
Journal:  Cancer Biother Radiopharm       Date:  2008-04       Impact factor: 3.099

10.  Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.

Authors:  Iris Verel; Gerard W M Visser; Ronald Boellaard; Otto C Boerman; Julliette van Eerd; Gordon B Snow; Adriaan A Lammertsma; Guus A M S van Dongen
Journal:  J Nucl Med       Date:  2003-10       Impact factor: 10.057

View more
  188 in total

1.  Preparation and biological evaluation of (64)Cu labeled Tyr(3)-octreotate using a phosphonic acid-based cross-bridged macrocyclic chelator.

Authors:  Yunjun Guo; Riccardo Ferdani; Carolyn J Anderson
Journal:  Bioconjug Chem       Date:  2012-06-18       Impact factor: 4.774

2.  Comparison of (64)Cu-complexing bifunctional chelators for radioimmunoconjugation: labeling efficiency, specific activity, and in vitro/in vivo stability.

Authors:  Maggie S Cooper; Michelle T Ma; Kavitha Sunassee; Karen P Shaw; Jennifer D Williams; Rowena L Paul; Paul S Donnelly; Philip J Blower
Journal:  Bioconjug Chem       Date:  2012-04-13       Impact factor: 4.774

Review 3.  Future Perspectives of Radionanomedicine Using the Novel Micelle-Encapsulation Method for Surface Modification.

Authors:  Yun-Sang Lee; Yong-Il Kim; Dong Soo Lee
Journal:  Nucl Med Mol Imaging       Date:  2015-08-07

4.  Novel Preparation Methods of (52)Mn for ImmunoPET Imaging.

Authors:  Stephen A Graves; Reinier Hernandez; Jesper Fonslet; Christopher G England; Hector F Valdovinos; Paul A Ellison; Todd E Barnhart; Dennis R Elema; Charles P Theuer; Weibo Cai; Robert J Nickles; Gregory W Severin
Journal:  Bioconjug Chem       Date:  2015-09-10       Impact factor: 4.774

5.  Novel (64)Cu-radiolabeled bile acid conjugates for targeted PET imaging.

Authors:  Hyun-Soon Chong; Yunwei Chen; Chi Soo Kang; Xiang Sun; Ningjie Wu
Journal:  Bioorg Med Chem Lett       Date:  2015-01-12       Impact factor: 2.823

6.  Dual-modality gene reporter for in vivo imaging.

Authors:  P Stephen Patrick; Jayne Hammersley; Louiza Loizou; Mikko I Kettunen; Tiago B Rodrigues; De-En Hu; Sui-Seng Tee; Robin Hesketh; Scott K Lyons; Dmitry Soloviev; David Y Lewis; Silvio Aime; Sandra M Fulton; Kevin M Brindle
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-17       Impact factor: 11.205

7.  Optimization of a Collagen-Targeted PET Probe for Molecular Imaging of Pulmonary Fibrosis.

Authors:  Pauline Désogère; Luis F Tapias; Tyson A Rietz; Nicholas Rotile; Francesco Blasi; Helen Day; Justin Elliott; Bryan C Fuchs; Michael Lanuti; Peter Caravan
Journal:  J Nucl Med       Date:  2017-06-13       Impact factor: 10.057

8.  Difluorocarbene-Derived Trifluoromethylthiolation and [(18)F]Trifluoromethylthiolation of Aliphatic Electrophiles.

Authors:  Jian Zheng; Lu Wang; Jin-Hong Lin; Ji-Chang Xiao; Steven H Liang
Journal:  Angew Chem Int Ed Engl       Date:  2015-09-21       Impact factor: 15.336

Review 9.  Tactics for preclinical validation of receptor-binding radiotracers.

Authors:  Susan Z Lever; Kuo-Hsien Fan; John R Lever
Journal:  Nucl Med Biol       Date:  2016-09-03       Impact factor: 2.408

Review 10.  Clinical applications of Gallium-68.

Authors:  Sangeeta Ray Banerjee; Martin G Pomper
Journal:  Appl Radiat Isot       Date:  2013-02-20       Impact factor: 1.513

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.